Ethic Inc. Invests $523,000 in The Cooper Companies, Inc. $COO

Ethic Inc. purchased a new stake in The Cooper Companies, Inc. (NASDAQ:COO) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 7,625 shares of the medical device company’s stock, valued at approximately $523,000.

Several other large investors have also modified their holdings of COO. Amundi increased its stake in Cooper Companies by 6.9% in the 1st quarter. Amundi now owns 982,828 shares of the medical device company’s stock worth $76,828,000 after purchasing an additional 63,365 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in shares of Cooper Companies by 48.9% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 22,407 shares of the medical device company’s stock worth $1,890,000 after acquiring an additional 7,363 shares in the last quarter. Nissay Asset Management Corp Japan ADV raised its holdings in shares of Cooper Companies by 1.4% during the first quarter. Nissay Asset Management Corp Japan ADV now owns 24,389 shares of the medical device company’s stock valued at $2,057,000 after acquiring an additional 335 shares during the period. Select Equity Group L.P. lifted its position in shares of Cooper Companies by 185.0% in the 1st quarter. Select Equity Group L.P. now owns 749,050 shares of the medical device company’s stock valued at $63,182,000 after acquiring an additional 486,241 shares in the last quarter. Finally, UniSuper Management Pty Ltd boosted its stake in Cooper Companies by 14.9% in the 1st quarter. UniSuper Management Pty Ltd now owns 27,919 shares of the medical device company’s stock worth $2,355,000 after purchasing an additional 3,625 shares during the period. 24.39% of the stock is owned by institutional investors.

Insider Buying and Selling at Cooper Companies

In other Cooper Companies news, CEO Albert G. White III purchased 10,000 shares of the company’s stock in a transaction on Tuesday, December 16th. The shares were bought at an average cost of $80.80 per share, with a total value of $808,000.00. Following the transaction, the chief executive officer directly owned 236,151 shares in the company, valued at approximately $19,081,000.80. This represents a 4.42% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Lawrence Erik Kurzius purchased 2,000 shares of Cooper Companies stock in a transaction on Wednesday, December 17th. The stock was bought at an average cost of $82.50 per share, with a total value of $165,000.00. Following the completion of the acquisition, the director owned 7,777 shares in the company, valued at approximately $641,602.50. This trade represents a 34.62% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have acquired 16,014 shares of company stock worth $1,304,416 in the last ninety days. 1.98% of the stock is owned by insiders.

Cooper Companies Price Performance

NASDAQ COO opened at $81.11 on Monday. The company has a 50 day moving average price of $76.67 and a two-hundred day moving average price of $72.87. The Cooper Companies, Inc. has a 12-month low of $61.78 and a 12-month high of $100.24. The stock has a market capitalization of $15.90 billion, a PE ratio of 43.14, a price-to-earnings-growth ratio of 2.32 and a beta of 1.03. The company has a quick ratio of 1.13, a current ratio of 1.89 and a debt-to-equity ratio of 0.30.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings data on Thursday, December 4th. The medical device company reported $1.15 earnings per share for the quarter, beating analysts’ consensus estimates of $1.11 by $0.04. The business had revenue of $1.07 billion for the quarter, compared to the consensus estimate of $1.06 billion. Cooper Companies had a return on equity of 10.02% and a net margin of 9.16%.The firm’s revenue was up 4.6% compared to the same quarter last year. During the same period last year, the business earned $1.04 EPS. Cooper Companies has set its FY 2026 guidance at 4.450-4.600 EPS and its Q1 2026 guidance at 1.020-1.040 EPS. As a group, equities analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Cooper Companies declared that its Board of Directors has approved a stock repurchase program on Wednesday, September 17th that permits the company to repurchase $2.00 billion in shares. This repurchase authorization permits the medical device company to purchase up to 15.4% of its shares through open market purchases. Shares repurchase programs are typically an indication that the company’s board of directors believes its shares are undervalued.

Analyst Upgrades and Downgrades

Several analysts have recently commented on the company. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Cooper Companies in a research report on Monday, December 29th. The Goldman Sachs Group reiterated a “sell” rating and issued a $71.00 target price (up previously from $64.00) on shares of Cooper Companies in a report on Monday, December 8th. Robert W. Baird boosted their price objective on shares of Cooper Companies from $85.00 to $98.00 and gave the company an “outperform” rating in a research report on Friday, December 5th. JPMorgan Chase & Co. upped their price objective on shares of Cooper Companies from $66.00 to $78.00 and gave the company a “neutral” rating in a research note on Friday, December 5th. Finally, KeyCorp reissued a “sector weight” rating on shares of Cooper Companies in a research note on Friday, December 5th. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, five have assigned a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $90.15.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.